Birinapant

Birinapant


Birinapant (TL32711) is a bivalent Smac mimetic and potent XIAP and cIAP1 antagonist that promotes cIAP degradation, caspase-8 activation, and tumor cell death by disrupting TNF-driven NF-κB signaling, making it a promising candidate for targeted cancer therapy.

Molecular structure of the compound BP-42843
    • Unit
    • Price
    • Qty
    • 25 MG
    • $210.00
    • 50 MG
    • $380.00
    • 100 MG
    • $540.00
    • 250 MG
    • $980.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire